Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status and Recruitment Status across versions, indicating changes in the trial's activity and enrollment status.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:08.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Release 3.2.0 includes a prominent government funding/operating status notice and updates the version from 3.1.0 to 3.2.0.
    Difference
    13%
    Check dated 2025-10-05T09:56:57.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T03:12:46.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added: Revision: v3.0.2. Deleted: Revision: v3.0.1 and Back to Top. The page now reflects the new revision and has removed a back-to-top UI element.
    Difference
    0.8%
    Check dated 2025-09-13T17:17:08.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.8%
    Check dated 2025-09-06T14:59:20.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    7%
    Check dated 2025-08-30T11:46:02.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.